Oral iloprost as a treatment for Raynaud's syndrome: a double blind multicentre placebo controlled study.

समान संसाधन

• A double blind, randomised, multicentre comparison of two doses of intravenous iloprost in the treatment of Raynaud's phenomenon secondary to connective tissue diseases.
  द्वारा: Torley, H I, और अन्य
  प्रकाशित: (1991)
• Comparison of intravenous infusions of iloprost and oral nifedipine in treatment of Raynaud's phenomenon in patients with systemic sclerosis: a double blind randomised study.
  द्वारा: Rademaker, M., और अन्य
  प्रकाशित: (1989)
• A multiclinic, placebo-controlled, double-blind study of prostaglandin E1 in Raynaud's syndrome.
  द्वारा: Mohrland, J S, और अन्य
  प्रकाशित: (1985)
• Randomised, double blind, placebo controlled trial of inosine pranobex in rheumatoid arthritis.
  द्वारा: Brzeski, M, और अन्य
  प्रकाशित: (1990)
• Dazoxiben, a thromboxane synthetase inhibitor, in the treatment of Raynaud's syndrome: A double-blind trial
  द्वारा: Belch, J. J. F., और अन्य
  प्रकाशित: (1983)